Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Malaria eradication requires the development of new drugs to combat drug-resistant parasites. We identified bisbenzylisoquinoline alkaloids isolated from that are active against blood stages. Synthesis of a library of 94 hemi-synthetic derivatives allowed to identify compound that kills multi-drug resistant clinical isolates in the nanomolar range (median IC ranging from 35 to 88 nM). Chemical optimization led to compound with significantly improved preclinical properties. delays the onset of parasitemia in infected mice and inhibits transmission stages (culture assays), and using membrane feeding assay in the vector. Compound also impairs development in sporozoite-infected hepatocytes, in the low micromolar range. Finally, by chemical pull-down strategy, we characterized the parasite interactome with trilobine derivatives, identifying protein partners belonging to metabolic pathways that are not targeted by the actual antimalarial drugs or implicated in drug-resistance mechanisms.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883252PMC
http://dx.doi.org/10.1016/j.isci.2023.105940DOI Listing

Publication Analysis

Top Keywords

hemisynthetic alkaloids
4
alkaloids derived
4
derived trilobine
4
trilobine antimalarials
4
antimalarials sustained
4
sustained activity
4
activity multidrug-resistant
4
multidrug-resistant malaria
4
malaria eradication
4
eradication requires
4

Similar Publications

Covering: 2000 to 2023This review presents the exceptional story of ophiobolin A (OphA) and sphaeropsidin A (SphA), a sesterterpene and a diterpene, respectively, which were initially isolated as fungal phytotoxins and subsequently shown to possess other interesting biological activities, including promising anticancer activities. Ophiobolin A is a phytotoxin produced by different fungal pathogens, all belonging to the genus. Initially, it was only known as a very dangerous phytotoxin produced by fungi attacking essential cereals, such as rice and barley.

View Article and Find Full Text PDF

Hemisynthetic alkaloids derived from trilobine are antimalarials with sustained activity in multidrug-resistant .

iScience

February 2023

Epigenetic Chemical Biology, Department of Structural Biology and Chemistry, Institut Pasteur, Université de Paris-Cité, UMR n°3523, CNRS, 28 Rue du Dr Roux, 75015 Paris, France.

Malaria eradication requires the development of new drugs to combat drug-resistant parasites. We identified bisbenzylisoquinoline alkaloids isolated from that are active against blood stages. Synthesis of a library of 94 hemi-synthetic derivatives allowed to identify compound that kills multi-drug resistant clinical isolates in the nanomolar range (median IC ranging from 35 to 88 nM).

View Article and Find Full Text PDF

Natural compounds have always represented an important source for new drugs. Although fungi represent one such viable source, to date, no fungal metabolite has been marketed as an anticancer drug. Based on our work with phytotoxins as potential chemical scaffolds and our recent findings involving three phytopathogenic fungi, i.

View Article and Find Full Text PDF

Radicinin (), is a fungal dihydropyranopyran-4,5-dione isolated together with some analogues, namely 3--radicinin, radicinol, 3--radicinol, and cochliotoxin (-), from the culture filtrates of the fungus , a foliar pathogen of buffelgrass (), an invasive weed in North America. Among the different metabolites showed target-specific activity against the host plant and no toxicity on zebrafish embryos, promoting its potential use to develop a natural bioherbicide formulation to manage buffelgrass. These data and the peculiar structural feature of suggested to carry out a structure-activity relationship study, preparing some key hemisynthetic derivatives and to test their phytotoxicity.

View Article and Find Full Text PDF

Narciclasine (1) is a plant growth regulator that has been previously demonstrated to be proapoptotic to cancer cells at high concentrations (> or = 1 microM). Data generated in the present study show that narciclasine displays potent antitumor effects in apoptosis-resistant as well as in apoptosis-sensitive cancer cells by impairing the organization of the actin cytoskeleton in cancer cells at concentrations that are not cytotoxic (IC(50) values of 30-90 nM). The current study further revealed that any chemical modification to the narciclasine backbone generally led to compounds of variable stability, weaker activity, or even the complete loss of antiproliferative effects in vitro.

View Article and Find Full Text PDF